期刊文献+

口腔黏膜癌变过程中Fas与FasL表达的相互关系 被引量:1

The Relationship of Fas and Fas L Protein Expression in Oral Carcinogenesis
下载PDF
导出
摘要 目的 初步探讨Fas和FasL蛋白在口腔黏膜癌前损害发生发展过程中的作用及变化规律。方法 分别选出正常口腔黏膜、上皮单纯增生、上皮轻度异常增生、上皮中度异常增生、上皮重度异常增生与原位癌、鳞状细胞癌标本 ,共 6 4例 ,采用免疫组织化学染色技术———酶标链亲和素生物素法 (LsAB)染色并进行光镜下观察。结果 多数口腔鳞癌显示Fas表达的下调和FasL表达的上调 ,同样的结果见于口腔癌前损害黏膜组织。结论 Fas和FasL的表达参与了口腔癌变过程 ,且可能是癌细胞逃避宿主免疫攻击的机制。Fas FasL系统有望成为判定口腔癌前损害预后的生物标志。 Objective The purpose of the study is to investigate the mechanism of immune escape and the expression of Fas and Fas L in oral premalignant lesions (OPLs) and oral squamous cell carcinomas (OSCCs).Methods 64 samples, including normal oral mucosa(7), hyperkeratosis(9), premalignant lesions(24) and squamous cell carcinomas(24), were studied. The cells in the test specimens, which demonstrate granular staining, were considered as positive. The expression of Fas and Fas L was evaluated semi-quantitatively as follows: -,no expression; +(mild),<5% positive cells; ++(moderate),6%~25% positive cells; +++(intense),26%~50% positive cells; or ++++(very intense),>50% positive cells.Results In the process of oral carcinogenesis, each stage had Fas expression. The positive staining appeared essentially on cell membrane. Various degrees of Fas expression were seen in the diseased tissues. The number of positively stained cells in the moderately and severely dysplastic tissues appeared higher than that in the normal control (P<0.05). In the OSCC group, the level of expression of Fas antigen decreased significantly by comparison with the normal controls (P<0.05). Fas L expression was discovered in each stage of the process of oral carcinogenesis. The positive staining appeared in cytoplasm. In hyperkeratotic tissues and OPLs, the number of Fas L expression cells was significantly higher than that in the normal controls. The number of Fas L expression cells of OSCCs increased by comparison with both normal controls and OPLs.Conclusion The results indicate that the expression of Fas and Fas L is involved in oral carcinogenesis and this may be directly related to the mechanism by which the cancer cells evade the host immune assault. Perhaps, Fas/Fas L system may be used as a prognostic biomarker in predicting the behavior of oral premalignant lesions in the near future.
出处 《华西口腔医学杂志》 CAS CSCD 北大核心 2003年第4期259-262,共4页 West China Journal of Stomatology
基金 国家自然科学基金资助项目 (编号 30 0 70 81 4 30 0 70 81 5)
关键词 口腔黏膜癌变 FAS FASL 表达 鳞状细胞癌 Fas Fas L oral premalignant lesion squamous cell cacinomous
  • 相关文献

参考文献12

  • 1聂敏海,陈谦明,李秉琦,曾先明,罗刚,曾昕.口腔粘膜癌变过程中浸润淋巴细胞定量病理学观察[J].临床口腔医学杂志,1997,13(4):213-215. 被引量:2
  • 2Nagata S. Apoptosis by death factor. Cell, 1997,88(3) :355-365.
  • 3Nagata S, Golstein P. The Fas death factor. Science, 1995, 267(5203) : 1449-1456.
  • 4Leithauser F, Dhein J, Mechtersheimer G, et al. Constitutive and induced expression of Apo-1 ,a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab lnvest, 1993,69(4) :415-429.
  • 5Frech LE, Hahne M, Viard I, et al. Fas and Fas ligand in embryos and adult mice:Ligand expression in several immune-privilegad tissues and coexpression in adult tissues characterized by apoptotic cell turnover. J Cell Biol, 1996,133(2) :335-343.
  • 6Strand S, Hofmann WJ, Hug H, et al. Lymphocyte apoptosis induced by CD95(Apo-1/Fas) ligand-exprssing tumor cells: A mechanism of immune evasion? Nat Med, 1996,2(12) : 1361-1366.
  • 7Hahne M, Rimoldi D, Schroter M, et al. Melanoma cell expression of Fas(Apo-1/CD95)ligand: Implications for tumor immune escape.Seienee, 1996,274(5291) :1363-1366.
  • 8Muraki Y, Yoshioka C, Fukuda J, et al. Immunohistochemical detection of Fas antigen in oral epithelia. J Oral Pathol Med, 1997,26( 2 ) : 57-62.
  • 9Sundelin K, Jadner M, Norberg-Spaak L, et al. Metallothionein and Fas(CD95) are expressed in squamous cell carcinoma of the tongue.Eur J Cancer, 1997,33(11) : 1860-1864.
  • 10Loro LL, Vintermyr OK, Johannessen AC, et al. Suppression of Fas receptor and negative correlation of Fas ligand with differentiation and apoptosis in oral squamous cell carcinoma. J Oral Pathol Med,1999,28(2) :62-67.

二级参考文献1

  • 1林震琼.癌周淋巴细胞反应对肺癌术后生存期的影响[J]肿瘤防治研究,1983(01).

共引文献1

同被引文献6

  • 1[7]Koga F, Arai K, Kamai T, et al. Fas labeling status does not correlate with apoptosis of renal cell carcinoma in vivo [ J ]. Anticancer Res,2001,21(5) :3193-3197.
  • 2[1]Koomagi R, Volm M. Expression of Fas( CD95/APO-1 ) and Fas ligand in lung cancer,its prognostic and predictive relevance[J].lnt J Cancer, 1999,84(3) :239-243.
  • 3[2]Nagao M, Nakajima Y, Hisanga M, et al. The relation of Fas receptor and ligand system in hepatocellular carcinomas: how do hepatoma cells escape from the host immune surveillance in vivo? [J]. Hepatology,1999,30(2) :413-421.
  • 4[3]Muraki Y, Yoshika C, Tateishi A, et al. Localization of fas antigen in oral squamous cell carcinoma[J]. Br J Oral Maxillofac Surg, 1999,37(1):37-41.
  • 5[5]Muraki Y, Yoshika C, Fukudal J, et al. Immunohistochemical detection of Fas antigen in oral epithelia[J]. J Oral Pathol Med, 1997,26(7) :57-62.
  • 6[6]Loro LL, Vintermyr OK, Johnnessen AC, et al. Suppression of Fas receptor and negtive correlation of Fas ligand with differentiation and apoptosis in oral squamous cell carcinoma[J]. J Oral Pathol Med, 1999,28(2) :82-87.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部